Chronic rejection: Failure of immune regulation

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Goodman, Jeremy ^a   Mohanakumar, Thalachallour ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Allotransplantation; Cellular Rejection; Chronic Rejection; Cytokines; Humoral Rejection; Regulatory Cells; Review

Indexed keywords

HLA ANTIBODY;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; GRAFT REJECTION; HEART GRAFT; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; KIDNEY GRAFT REJECTION; LIVER GRAFT; LUNG TRANSPLANTATION; NONHUMAN; REVIEW; T LYMPHOCYTE; ANIMAL; CHRONIC DISEASE; IMMUNOLOGY; MOUSE;

ANIMALS; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; MICE;

EID: 4344653857     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. http://www.optn.org/latestData/rptData.asp
2. http://www.ustransplant.org/annual_reports/ar02/ ar01_table_113_surv%7Enew_dh.html
3. Norman D and L Turka: Primer on Transplantation. American Society of Transplantation, Mount Laurel (2001)
4. Racusen LC, K Solez, RB Colvin, SM Bonsib, MC Castro, T Cavallo, BP Croker, AJ Demetris, CB Drachenberg, AB Fogo, P Furness, LW Gaber, IW Gibson, D Glotz, JC Goldberg, J Grande, PF Halloran, HE Hansen, B Hartley, PJ Hayry, CM Hill, EO Hoffman, LG Hunsicker, AS Lindblad, Y Yamaguchi, and et al.: The Banff 97 working classification of renal allograft pathology. Kidney Int 55, 713-23 (1999)
5. Smith CR, A Jaramillo, KC Lu, T Higuchi, Z Kaleem, and T Mohanakumar: Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor. Transplantation 72, 1512-8 (2001)
6. Patel R and PI Terasaki: Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280, 735-9 (1969)
7. Lenhard V, W Rettwitz, K Dreikorn, and L Rohl: Prognostic significance of B and T cell antibodies in kidney transplantation. Proc Eur Dial Transplant Assoc 17, 478-82 (1980)
8. Gailiunas P, Jr., M Suthanthiran, GJ Busch, CB Carpenter, and MR Garovoy: Role of humoral presenitization in human renal transplant rejection. Kidney Int 17, 638-46 (1980)
9. Smith MA, A Jaramillo, KS SivaSai, B Naziruddin, Z Kaleem, GA Patterson, and T Mohanakumar: Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts. Transplantation 73, 186-93 (2002)
10. McKane BW, EP Trulock, GA Patterson, and T Mohanakumar: Lung transplantation and bronchiolitis obliterans: an evolution in understanding. Immunol Res 24, 177-90 (2001)
11. Palmer SM, RD Davis, D Hadjiliadis, MI Hertz, DN Howell, FE Ward, K Savik, and NL Reinsmoen: Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 74, 799-804 (2002)
12. El-Awar N, P Terasaki, V Lazda, A Nikaein, C Manning, and AN Arnold: Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Transplant Proc 34, 2531-2 (2002)
13. Lee PC, PI Terasaki, SK Takemoto, PH Lee, CJ Hung, YL Chen, A Tsai, and HY Lei: All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74, 1192-4 (2002)
14. Mauiyyedi S, PD Pelle, S Saidman, AB Collins, M Pascual, NE Tolkoff-Rubin, WW Williams, AA Cosimi, EE Schneeberger, and RB Colvin: Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12, 574-82 (2001)
15. Paul LC, WM Baldwin, 3rd, and LA van Es: Vascular endothelial alloantigens in renal transplantation. Transplantation 40, 117-23 (1985)
16. Moraes J and P Statsny: Allo-antibodies to endothelial cell antigens. In: Histocompatibility Testing 1975. Eds: Kissmeyer-Nielsen, Munksgaard, Copenhagen (1976)
17. Joyce S, MW Flye, and T Mohanakumar: Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies eluted from rejected human renal allografts. Transplantation 46, 362-9 (1988)
18. Jaramillo A, B Naziruddin, L Zhang, SI Reznik, MA Smith, AA Aloush, EP Trulock, GA Patterson, and T Mohanakumar: Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 71, 966-76 (2001)
19. Mathew JM, S Joyce, W Lawrence, and T Mohanakumar: Evidence that antibodies eluted from rejected kidneys of HLA-identical transplants define a non-MHC alloantigen expressed on human kidneys. Transplantation 52, 559-62 (1991)
20. al-Hussein KA, D Talbot, G Proud, RM Taylor, and BK Shenton: The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl Int 8, 214-20 (1995)
21. Fredrich R, M Toyoda, LS Czer, K Galfayan, O Galera, A Trento, D Freimark, S Young, and SC Jordan: The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 67, 385-91 (1999)
22. Slachta CA, V Jeevanandam, B Goldman, WL Lin, and CD Platsoucas: Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). J Immunol 165, 3469-83 (2000)
23. Kusaka S, AP Grailer, JH Fechner, Jr., E Jankowska-Gan, T Oberley, HW Sollinger, and WJ Burlingham: Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient. J Immunol 164, 2240-7 (2000)
24. Sun H, V Subbotin, J Woodward, L Valdivia, JJ Fung, and AS Rao: Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection. Transplant Proc 33, 319 (2001)
25. Fischbein MP, J Yun, H Laks, Y Irie, MC Fishbein, B Bonavida, and A Ardehali: Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 123, 803-9 (2002)
26. Legare JF, T Issekutz, TD Lee, and G Hirsch: CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol 157, 859-65 (2000)
27. Higuchi T, A Jaramillo, Z Kaleem, GA Patterson, and T Mohanakumar: Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation 74, 646-51 (2002)
28. Lee RS, K Yamada, SL Houser, KL Womer, ME Maloney, HS Rose, MH Sayegh, and JC Madsen: Indirect allorecognition promotes the development of cardiac allograft vasculopathy. Transplant Proc 33, 308-10 (2001)
29. Baker RJ, MP Hernandez-Fuentes, PA Brookes, AN Chaudhry, and R Lechler: Comparison of the direct and indirect pathways of allorecognition in chronic allograft failure. Transplant Proc 33, 449 (2001)
30. Reznik SI, A Jaramillo, KS SivaSai, KL Womer, MH Sayegh, EP Trulock, GA Patterson, and T Mohanakumar: Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 1, 228-35 (2001)
31. Smith CR, A Jaramillo, W Liu, Y Tu, Z Kaleem, CJ Swanson, and T Mohanakumar: CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts. Transplantation 71, 1640-8 (2001)
32. Laskowski IA, J Pratschke, MJ Wilhelm, VM Dong, F Beato, M Taal, M Gasser, WW Hancock, MH Sayegh, and NL Tilney: Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 13, 519-27 (2002)
33. Kita Y, XK Li, M Ohba, N Funeshima, S Enosawa, H Nogimura, S Ohi, Y Kageyama, K Matsushita, Y Ito, T Takahashi, K Suzuki, S Suzuki, and T Kazui: Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas. Transplant Proc 32, 2036-7 (2000)
34. van Kooten C: Blockade of costimulatory pathways of T-cell activation: the solution to acute and chronic rejection? Curr Opin Nephrol Hypertens 8, 675-80 (1999)
35. Gagne K, S Brouard, M Giral, F Sebille, A Moreau, M Guillet, JD Bignon, BM Imbert, MC Cuturi, and JP Soulillou: Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol 164, 1553-63 (2000)
36. Karim M, AR Bushell, and KJ Wood: Regulatory T cells in transplantation. Curr Opin Immunol 14, 584-91 (2002)
37. Kato M, T Matsuguchi, Y Ono, R Hattori, S Ohshima, and Y Yoshikai: Characterization of CD28(-)CD4(+) T cells in living kidney transplant patients with long-term allograft acceptance. Hum Immunol 62, 1335-45 (2001)
38. Colovai AI, M Mirza, G Vlad, S Wang, E Ho, R Cortesini, and N Suciu-Foca: Regulatory CD8+CD28- T cells in heart transplant recipients. Hum Immunol 64, 31-7 (2003)
39. Renna Molajoni E, P Cinti, E Ho, B Evangelista, D Peritore, L Poli, R Pretagostini, P Berloco, N Suciu Foca Cortesini, and R Cortesini: Allospecific human T suppressor cells in kidney transplantation. Transplant Proc 33, 1129-30 (2001)
40. Conti F, Y Calmus, E Rouer, P Gaulard, A Louvel, D Houssin, and ES Zafrani: Increased expression of interleukin-4 during liver allograft rejection. J Hepatol 30, 935-43 (1999)
41. Lu KC, A Jaramillo, RL Lecha, RB Schuessler, A Aloush, EP Trulock, EN Mendeloff, CB Huddleston, G Alexander Patterson, and T Mohanakumar: Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 74, 1297-302 (2002)
42. Awad MR, A El-Gamel, P Hasleton, DM Turner, PJ Sinnott, and IV Hutchinson: Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66, 1014-20 (1998)
43. Shirwan H: Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 68, 715-26 (1999)
44. Kist-van Holthe JE, M Gasser, K Womer, N Najafian, V Dong, DV Samsonov, CS Geehan, A Chandraker, MH Sayegh, and AM Waaga: Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 62, 627-31 (2002)
45. Gao W, PS Topham, JA King, ST Smiley, V Csizmadia, B Lu, CJ Gerard, and WW Hancock: Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 105, 35-44 (2000)
46. Rodrigo E, M Lopez Hoyos, R Escallada, JC Ruiz, GF Fresnedo, M Heras, C Pinera, MA Ramos, JG Cotorruelo, and M Arias: Changes in serum concentrations of matrix metalloproteinases in kidney transplantation. Transplant Proc 32, 517-8 (2000)
47. Beeh KM, J Beier, O Kornmann, P Micke, and R Buhl: Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 20, 1144-51 (2001)
48. Brazelton TR, B Adams, R Shorthouse, and RE Morris: Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapies. Inflamm Res 48 Suppl 2, S134-5 (1999)